STOCK TITAN

[Form 4] DIVERSIFIED HEALTHCARE TRUST Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Adam D. Portnoy, a director of Diversified Healthcare Trust (NASDAQ: DHC), reported a sale of 15,226 common shares on 09/16/2025 at a price of $4.37 per share. The filing lists 415,156.55 shares as his direct beneficial ownership following the transaction and indicates an indirect interest of 23,250,019 shares held by ABP Trust, for which Mr. Portnoy is sole trustee; he disclaims beneficial ownership except to the extent of his pecuniary interest. The filing explains the sale code as F, reflecting withholding of shares to satisfy a tax liability arising from vesting. The Form 4 was signed on 09/18/2025.

Adam D. Portnoy, direttore della Diversified Healthcare Trust (NASDAQ: DHC), ha segnalato la vendita di 15.226 azioni ordinarie il 16/09/2025 al prezzo di $4.37 per azione. La dichiarazione mostra 415.156,55 azioni come sua proprietà diretta beneficiaria dopo la transazione e indica un interesse indiretto di 23.250.019 azioni detenuto da ABP Trust, per le quale il signor Portnoy è unico fiduciario; egli disconosce la proprietà benefica salvo in quanto riguarda il proprio interesse pecuniario. La dichiarazione spiega il codice di vendita come F, che riflette la trattenuta di azioni per soddisfare un obbligo fiscale derivante dalla vestizione. Il Form 4 è stato firmato il 18/09/2025.

Adam D. Portnoy, director de Diversified Healthcare Trust (NASDAQ: DHC), informó la venta de 15.226 acciones comunes el 16/09/2025 a un precio de $4.37 por acción. La declaración señala 415.156,55 acciones como su propiedad directa y beneficiosa tras la operación e indica un interés indirecto de 23.250.019 acciones en ABP Trust, del cual el Sr. Portnoy es el fiduciario único; él renuncia a la propiedad beneficiosa salvo en la medida de su interés pecuniario. La declaración explica el código de venta como F, que refleja la retención de acciones para satisfacer una obligación tributaria derivada de la vesting. El Form 4 fue firmado el 18/09/2025.

Adam D. Portnoy, Diversified Healthcare Trust(NASDAQ: DHC)의 이사로, 15,226주의 일반주를 2025-09-16에 매도했다고 보고했습니다. 주당 매매가 $4.37입니다. 보고서에 매매 이후 그의 직접적 유익소유로 415,156.55주가 기재되었으며, 포트노이가 단독 수탁자인 ABP 트러스트가 보유한 간접적 이해관계 23,250,019주가 표시됩니다. 그는 재정적 이해관계 범위 밖에서 실질적 소유권을 포기합니다. 보고서는 매도 코드를 F로 설명하는데, 이는 과세 부채를 충당하기 위해 주식을 보류했음을 나타냅니다. 양식 4는 2025-09-18에 서명되었습니다.

Adam D. Portnoy, administrateur de Diversified Healthcare Trust (NASDAQ: DHC), a signalé la vente de 15 226 actions ordinaires le 16/09/2025 à un prix de $4.37 par action. Le dépôt indique 415 156,55 actions en tant que propriété bénéficiaire directe après la transaction et indique un intérêt indirect de 23 250 019 actions détenu par ABP Trust, dont M. Portnoy est le seul fiduciaire; il déclare renoncer à la propriété bénéficiaire à l’exception de son intérêt pécuniaire. Le dépôt décrit le code de vente comme F, reflétant la retenue des actions pour satisfaire une obligation fiscale résultant de la vesting. Le Formulaire 4 a été signé le 18/09/2025.

Adam D. Portnoy, Direktor der Diversified Healthcare Trust (NASDAQ: DHC), meldete den Verkauf von 15.226 Stammaktien am 16.09.2025 zu einem Kurs von $4.37 pro Aktie. Die Einreichung verzeichnet 415.156,55 Aktien als direkte wohltätige Eigentümerschaft nach der Transaktion und gibt ein indirektes Interesse von 23.250.019 Aktien an, das von der ABP Trust gehalten wird, für den Portnoy alleiniger Treuhänder ist; er verzichtet auf wirtschaftliches Eigentum außerhalb seines finanziellen Interesses. Die Einreichung erklärt den Verkaufs Code als F, der die Zurückhaltung von Aktien zur Begleichung einer steuerlichen Verpflichtung aufgrund der Vesting widerspiegelt. Das Formular 4 wurde am 18.09.2025 unterzeichnet.

آدام د. بورنوي، مدير في Diversified Healthcare Trust (ناسداك: DHC)، أبلغ عن بيع 15,226 سهماً عادياً في 16/09/2025 بسعر $4.37 للسهم. تشير الوثيقة إلى 415,156.55 سهماً كملكية مباشرة مستفيدة بعد الصفقة وتوضح وجود مصالح غير مباشرة من 23,250,019 سهماً مملوكة لـ ABP Trust، الذي يشغل السيد Portnoy فيه الوصي الوحيد؛ وهو يتنصل من الملكية المفيدة باستثناء مصلحته المالية. تشرح الوثيقة رمز البيع بـ F، الذي يعكس حجز الأسهم لتلبية التزام ضريبي ناتج عن الاستحقاق. وقع النموذج 4 في 18/09/2025.

Adam D. Portnoy,Diversified Healthcare Trust(纳斯达克代码:DHC)的董事,报告在< b>2025-09-16以每股$4.37的价格出售了15,226普通股。申报显示交易后其直接受益所有权为415,156.55股,并指出由ABP Trust持有的23,250,019股间接权益;Portnoy先生为其唯一受托人;他在可得经济利益范围之外否认实际所有权。申报将出售代码解释为F,表示为满足税务义务而扣留股票。Form 4 于2025-09-18签署。

Positive
  • Timely disclosure of insider sale under Section 16
  • Sale clearly explained as tax-withholding related to vesting (Transaction Code F)
  • Indirect holdings disclosed showing transparency about material trust ownership
Negative
  • Director sold shares which could be perceived negatively by some investors despite tax explanation
  • Indirect trust holds 23,250,019 shares where the reporter disclaims beneficial ownership except to pecuniary interest, leaving limited clarity on control extent

Insights

TL;DR: Routine insider withholding sale disclosed; large indirect trust holdings noted.

The reported transaction is a common administrative sale where shares are withheld to cover taxes on vested securities, as indicated by Transaction Code F and the filing explanation. This reduces direct holdings modestly while leaving a substantial indirect position via ABP Trust. From a governance perspective, timely filing and clear attribution of indirect holdings align with disclosure best practices. The trustee relationship to ABP Trust is disclosed but Mr. Portnoy explicitly disclaims beneficial ownership beyond his pecuniary interest, which is standard language for trust-held shares.

TL;DR: Small sale size and tax-withholding rationale make this a neutral, non-material insider event.

The sale of 15,226 shares at $4.37 appears administrative rather than an investment signal given the stated tax-withholding purpose. Direct ownership reported after the sale is shown as 415,156.55 shares while indirect holdings of 23,250,019 shares through ABP Trust remain significant; the filing does not quantify Mr. Portnoy’s pecuniary interest in the trust. There is no indication of derivative transactions or other material changes to overall insider exposure beyond this withholding action.

Adam D. Portnoy, direttore della Diversified Healthcare Trust (NASDAQ: DHC), ha segnalato la vendita di 15.226 azioni ordinarie il 16/09/2025 al prezzo di $4.37 per azione. La dichiarazione mostra 415.156,55 azioni come sua proprietà diretta beneficiaria dopo la transazione e indica un interesse indiretto di 23.250.019 azioni detenuto da ABP Trust, per le quale il signor Portnoy è unico fiduciario; egli disconosce la proprietà benefica salvo in quanto riguarda il proprio interesse pecuniario. La dichiarazione spiega il codice di vendita come F, che riflette la trattenuta di azioni per soddisfare un obbligo fiscale derivante dalla vestizione. Il Form 4 è stato firmato il 18/09/2025.

Adam D. Portnoy, director de Diversified Healthcare Trust (NASDAQ: DHC), informó la venta de 15.226 acciones comunes el 16/09/2025 a un precio de $4.37 por acción. La declaración señala 415.156,55 acciones como su propiedad directa y beneficiosa tras la operación e indica un interés indirecto de 23.250.019 acciones en ABP Trust, del cual el Sr. Portnoy es el fiduciario único; él renuncia a la propiedad beneficiosa salvo en la medida de su interés pecuniario. La declaración explica el código de venta como F, que refleja la retención de acciones para satisfacer una obligación tributaria derivada de la vesting. El Form 4 fue firmado el 18/09/2025.

Adam D. Portnoy, Diversified Healthcare Trust(NASDAQ: DHC)의 이사로, 15,226주의 일반주를 2025-09-16에 매도했다고 보고했습니다. 주당 매매가 $4.37입니다. 보고서에 매매 이후 그의 직접적 유익소유로 415,156.55주가 기재되었으며, 포트노이가 단독 수탁자인 ABP 트러스트가 보유한 간접적 이해관계 23,250,019주가 표시됩니다. 그는 재정적 이해관계 범위 밖에서 실질적 소유권을 포기합니다. 보고서는 매도 코드를 F로 설명하는데, 이는 과세 부채를 충당하기 위해 주식을 보류했음을 나타냅니다. 양식 4는 2025-09-18에 서명되었습니다.

Adam D. Portnoy, administrateur de Diversified Healthcare Trust (NASDAQ: DHC), a signalé la vente de 15 226 actions ordinaires le 16/09/2025 à un prix de $4.37 par action. Le dépôt indique 415 156,55 actions en tant que propriété bénéficiaire directe après la transaction et indique un intérêt indirect de 23 250 019 actions détenu par ABP Trust, dont M. Portnoy est le seul fiduciaire; il déclare renoncer à la propriété bénéficiaire à l’exception de son intérêt pécuniaire. Le dépôt décrit le code de vente comme F, reflétant la retenue des actions pour satisfaire une obligation fiscale résultant de la vesting. Le Formulaire 4 a été signé le 18/09/2025.

Adam D. Portnoy, Direktor der Diversified Healthcare Trust (NASDAQ: DHC), meldete den Verkauf von 15.226 Stammaktien am 16.09.2025 zu einem Kurs von $4.37 pro Aktie. Die Einreichung verzeichnet 415.156,55 Aktien als direkte wohltätige Eigentümerschaft nach der Transaktion und gibt ein indirektes Interesse von 23.250.019 Aktien an, das von der ABP Trust gehalten wird, für den Portnoy alleiniger Treuhänder ist; er verzichtet auf wirtschaftliches Eigentum außerhalb seines finanziellen Interesses. Die Einreichung erklärt den Verkaufs Code als F, der die Zurückhaltung von Aktien zur Begleichung einer steuerlichen Verpflichtung aufgrund der Vesting widerspiegelt. Das Formular 4 wurde am 18.09.2025 unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
PORTNOY ADAM D.

(Last) (First) (Middle)
C/O THE RMR GROUP LLC
TWO NEWTON PL., 255 WASH. ST., STE. 300

(Street)
NEWTON MA 02458

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DIVERSIFIED HEALTHCARE TRUST [ NASDAQ:DHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/16/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares of Beneficial Interest 09/16/2025 F(1) 15,226 D $4.37 415,156.55 D
Common Shares of Beneficial Interest 23,250,019 I See Footnote(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Payment of tax liability by withholding securities incident to the vesting of the security issued in accordance with Rule 16b-3.
2. These shares are held by ABP Trust; Mr. Portnoy, as the sole trustee, an officer and the controlling shareholder of ABP Trust, may be deemed to be a beneficial owner of these shares, but Mr. Portnoy disclaims such beneficial ownership except to the extent of his pecuniary interest therein.
/s/ Adam D. Portnoy 09/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Diversified Healthcare Trust insider Adam Portnoy disclose on Form 4?

The filing shows a sale of 15,226 common shares on 09/16/2025 at $4.37 per share and reports direct and indirect holdings following the transaction.

Why were shares sold by Adam Portnoy according to the Form 4?

The sale used Transaction Code F, indicating shares were withheld to pay a tax liability arising from vested securities.

How many shares does Adam Portnoy beneficially own after the reported transaction?

The form reports 415,156.55 shares as direct beneficial ownership and an indirect interest of 23,250,019 shares held by ABP Trust.

Does Adam Portnoy claim beneficial ownership of the ABP Trust shares?

The filing states Mr. Portnoy may be deemed a beneficial owner as sole trustee but explicitly disclaims such beneficial ownership

When was the Form 4 signed and filed?

The Form 4 is signed by Adam D. Portnoy with a signature date of 09/18/2025.
Diversified Healthcare Tr

NASDAQ:DHC

DHC Rankings

DHC Latest News

DHC Latest SEC Filings

DHC Stock Data

1.06B
216.76M
10.23%
75.86%
2.07%
REIT - Healthcare Facilities
Real Estate Investment Trusts
Link
United States
NEWTON